We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Testing Results of the BioOdyssey Calligrapher MiniArrayer for Clinical Research Available
News

Testing Results of the BioOdyssey Calligrapher MiniArrayer for Clinical Research Available

Testing Results of the BioOdyssey Calligrapher MiniArrayer for Clinical Research Available
News

Testing Results of the BioOdyssey Calligrapher MiniArrayer for Clinical Research Available

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Testing Results of the BioOdyssey Calligrapher MiniArrayer for Clinical Research Available"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bio-Rad Laboratories, Inc. has announced the availability of a technical bulletin (bulletin 5534A), that describes results of the testing of the BioOdyssey™ Calligrapher™ MiniArrayer, which is used for the printing of protein microarrays.

The widespread application of microarray technology to clinical research and clinical trials requires the ability to assess the technical and quality aspects of robotic devices that are used to construct the arrays.

Instruments approved for use in human clinical diagnostic laboratories must undergo extensive quality assessments, including documentation of accuracy, precision, linearity, and sensitivity for a given assay. As in a clinical setting, it is necessary to understand the capabilities and limitations of a robotic microarray printing device.

Bio-Rad’s bulletin 5534A provides an analysis of the issues associated with microarray printing and offers testing results of the BioOdyssey Calligrapher MiniArrayer that can be used to assess microarray printing results.

Along with a detailed introduction, the six-page bulletin uses diagrams, tables, and graphics to provide an extensive description of methods used in the evaluation.

Results of the evaluation confirm that the BioOdyssey Calligrapher MiniArrayer is technically capable to print reverse-phase microarrays (RPPAs) in batches up to 16 slides. Inter- and intra-slide CVs were <10% as evidenced through printing standard curves in replicates.

Advertisement